Filed: 11/7/2022ACC: 0000950123-22-010986
📋 What this filing means
REVELATION CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $4.3K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$4.3K
Total AUM (reported)
1.70M
Total Shares
Allocation by class
COM$4.3K100.0%
Portfolio Concentration
Top 3$4.3K100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 1.70M
Sole
Full voting authority
1.70M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
SINGULAR GENOMICS SYSTEMS INC
SOLEShares1.42M
TypeSH
Market value$3.5K
83.16%
Sole
1.42M
Shared
0.00
None
0.00
AKILI INC
SOLEShares245.91K
TypeSH
Market value$556.00
13.06%
Sole
245.91K
Shared
0.00
None
0.00
NEUROPACE INC
SOLEShares42.97K
TypeSH
Market value$161.00
3.78%
Sole
42.97K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SINGULAR GENOMICS SYSTEMS INCSOLE | COM | 1.42M | SH | $3.5K 83.16% | 1.42M | 0.00 | 0.00 |
AKILI INCSOLE | COM | 245.91K | SH | $556.00 13.06% | 245.91K | 0.00 | 0.00 |
NEUROPACE INCSOLE | COM | 42.97K | SH | $161.00 3.78% | 42.97K | 0.00 | 0.00 |